Artiva Biotherapeutics, Inc. (ARTV) Total liabilities 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) total liabilities at each fiscal year-end, per SEC filings.
$21.0MFY2025 · since FY2023: $50.7M → $21.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $21.0M | -8.6% |
| FY2024 | $22.9M | -54.8% |
| FY2023 | $50.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice